secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2026-08-06T21:04:48+00:00
Accession:  0001437749-26-026351
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences enters $75M at-the-market equity distribution agreement with Mizuho
--------------------------------------------------------------------------------

- Aggregate offering price of up to $75M of common stock via ATM facility.
- Mizuho Securities USA LLC acts as sales agent; commission up to 3.0% of gross proceeds.
- Sales may be made on Nasdaq or in negotiated transactions at prevailing market prices.
- Company is not obligated to sell any shares and may suspend offerings at any time.
- Prospectus supplement filed August 6, 2026 under existing S-3 registration statement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926026351/0001437749-26-026351-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926026351/plse20260806_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-026351

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer